{
    "SPADE_UN_15898": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_15898",
            "Peptide Name": "PTPRJ pep-19.3",
            "Source": "Synthetic (Derived from PTPRJ pep-19)",
            "Family": "",
            "Gene": "Not found",
            "Sequence": "CHANLTHAC",
            "Sequence Length": 9,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/Notavailable"
            ],
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Anticancer"
            ],
            "Target Organism": "Tumor cells:HeLa (28 ± 5.5% Inhibition=160 μM); HeLa (46 ± 4.2% Inhibition=160 μM); HeLa (51 ± 1.4% Inhibition=160 μM)",
            "Hemolytic Activity": "Not available",
            "Cytotoxicity": "Not available",
            "Binding Target": "PTPRJ",
            "Linear/Cyclic": "Cyclic",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C38H60N14O12S2",
            "Mass": 969.1,
            "PI": 6.9,
            "Net Charge": 2,
            "Hydrophobicity": 0.2,
            "Half Life": "Mammalian:1.2 hourYeast:>20 hourE.coli:>10 hour",
            "Comments": "PTPRJ is a receptor-type protein tyrosine phosphatase whose expression is strongly reduced in the majority of investigated cancer cell lines and tumor specimens.It showed tumor suppressor activity in several models.",
            "Literature": [
                {
                    "Title": "Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation",
                    "Pubmed ID": "23627474",
                    "Reference": "ACS Chem Biol. 2013 Jul 19;8(7)1497-506.",
                    "Author": "Ortuso F, Paduano F, Carotenuto A, Gomez-Monterrey I, Bilotta A, Gaudio E, Sala M, Artese A, Vernieri E, Dattilo V, Iuliano R, Brancaccio D, Bertamino A, Musella S, Alcaro S, Grieco P, Perrotti N, Croce CM, Novellino E, Fusco A, Campiglia P, Trapasso F.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=23627474"
                }
            ],
            "Frequent Amino Acids": "ACH",
            "Absent Amino Acids": "DEFGIKMOPQRSUVWY",
            "Basic Residues": 2,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 3,
            "Polar Residues": 8,
            "Positive Residues": 2,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_07222",
                    "Similarity": 1.0,
                    "Sequence": "HACTVNADCEQSMCDPFCVGGYHFTPICVIGWCVCVGNRVAPVL"
                },
                {
                    "SPADE_ID": "SPADE_UN_15896",
                    "Similarity": 0.8888888888888888,
                    "Sequence": "CHHNLTHAC"
                },
                {
                    "SPADE_ID": "SPADE_UN_15897",
                    "Similarity": 0.7777777777777778,
                    "Sequence": "CAHNLTHAC"
                }
            ]
        }
    }
}